跳至主要内容
临床试验/IRCT20200922048804N1
IRCT20200922048804N1已完成未知

Inflammation control in patients with COVID-19 using melatonin supplement compare to controls referred to Imam Khomani Hospital

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • mild to moderate patients with COVID-19 who receive Hydroxy chloroquine
  • Confirmation of the disease is based on CT scan and clinical symptoms and physician diagnosis
  • Patients 25-65 years

排除标准

  • Patient with depression, COPD, sleep apnea and seizure
  • Patients with severe kidney problem (eGFR<30 ml/min)
  • Patients with severe liver problem
  • Patients who receive fluvoxamine, benzodiazepine or zolpidem
  • patients who receive drugs that extends QT
  • Pregnant and breastfeeding mothers
  • Patients who have allergy to melatonin

研究者

相似试验